Cases | 3′/5′^{a} | FISH | RT-PCR | IHC | Pathol. |
---|---|---|---|---|---|
782 | 49.5 | P | V3a/b | – | A |
981 | 64.8 | P | E17b ins 39;A20 | – | A |
654 | 78.4 | P | N | – | A |
460 | 241.3 | P | V1 | – | A |
1,474 | 63.1 | P | N | + | A |
399 | 78.2 | P | V3a/b | + | A |
490 | 130.6 | P | V3a/b | + | A |
636 | 300.2 | P | V1 | + | A |
667 | 556.4 | P | V1 | + | A |
93 | 867.1 | P | N | + | AS |
834 | 32.2 | P | V1 | ++ | A |
732 | 36.7 | P | V2 | ++ | A |
988 | 39.6 | P | E10a/b, E13;A20 | ++ | A |
788 | 51.6 | P | V3a/b | ++ | A |
1,335 | 83.2 | P | V1 | ++ | A |
1,004 | 88 | P | V1 | ++ | A |
781 | 103.2 | P | V3b | ++ | A |
1,003 | 121.9 | P | V1 | ++ | AS |
578 | 494.6 | P | V1 | ++ | A |
81 | 101.1 | P | N | +++ | A |
1,514 | 109.9 | P | V1 | +++ | A |
737 | 145.4 | P | E17 ins 65;A20 | +++ | A |
877 | 206.5 | P | V2 | +++ | A |
26 | 228.1 | P | V1 | +++ | AS |
245 | 248.9 | P | V1 | +++ | A |
1,451 | 261.3 | P | V1 | +++ | A |
966 | 296.1 | P | V2 | +++ | A |
1,228 | 393.4 | P | V1 | +++ | A |
1,494 | 427.5 | P | E6a/b ins 18;A20 | +++ | A |
324 | 568.1 | P | V2 | +++ | A |
1,523 | 685 | P | E6a;A19 | +++ | A |
584 | 714.1 | P | E17;A20 | +++ | A |
B56 | 731.5 | P | V3a/b | +++ | A |
563 | 879.2 | P | V1 | +++ | AS |
1,459 | 1,144.1 | P | V1 | +++ | A |
591 | 1,226.2 | P | V3a/b | +++ | A |
964 | 1,260.6 | P | V2 | +++ | A |
347 | 1,341.8 | P | V1 | +++ | A |
B36 | 1,422.8 | P | V1 | +++ | A |
1,141 | 1,573.7 | P | V1 | +++ | A |
NOTE: P, positive; N, negative; Pathol., pathology; A, adenocarcinoma; AS, adenosquamous carcinoma. V1,E13;A20, V2,E20;A20, V3a/b, E6a/b;A20.
↵^{a}Expression in 3′ portion of ALK mRNA relative to 5′ portion.